Peter Schmid
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 85
- Cancer Treatment and Pharmacology 40
- HER2/EGFR in Cancer Research 22
- Cancer Immunotherapy and Biomarkers 18
-
- Advanced Breast Cancer Therapies 28
- Co-authors
- Andrew Conrad (5 shared papers)Philip Savage (11 shared papers)Dave S.�B. Hoon (3 shared papers)Kurt Possinger (14 shared papers)Javier Cortés (22 shared papers)Tilman Steinert (9 shared papers)D L Morton (2 shared papers)Bernd Flath (11 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Oncology (14 papers)Cancer Research (13 papers)Medicine & Science in Sports & Exercise (10 papers)Anti-Cancer Drugs (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Peter Schmid
185 papers receiving 4.6k citations
Peter Schmid's Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 1.9k
- Cancer Research 732
- Biological Psychiatry 107
- Complementary and alternative medicine 347
- Immunology 619
Countries citing papers authored by Peter Schmid
This map shows the geographic impact of Peter Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schmid more than expected).
Fields of papers citing papers by Peter Schmid
This network shows the impact of papers produced by Peter Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schmid. The network helps show where Peter Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study Hit paper breakdown → | 2020 | 279 |
| 2 | 1995 | 271 | |
| 3 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Hit paper breakdown → | 2022 | 176 |
| 4 | 2009 | 160 | |
| 5 | 2020 | 146 | |
| 6 | Melanoma-associated antigens as messenger RNA detection markers for melanoma. | 1997 | 145 |
| 7 | 2006 | 106 | |
| 8 | 2006 | 100 | |
| 9 | 1997 | 93 | |
| 10 | 2003 | 85 | |
| 11 | 2019 | 84 | |
| 12 | 1996 | 82 | |
| 13 | 2008 | 81 | |
| 14 | 2007 | 78 | |
| 15 | 1996 | 72 | |
| 16 | 2007 | 65 | |
| 17 | 2003 | 65 | |
| 18 | 2010 | 64 | |
| 19 | 2007 | 63 | |
| 20 | 2015 | 62 |
About Peter Schmid
Peter Schmid is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology, having authored 198 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (40 papers), Advanced Breast Cancer Therapies (28 papers), Breast Cancer Treatment Studies (26 papers), HER2/EGFR in Cancer Research (22 papers), Cardiovascular and exercise physiology (20 papers), Cancer Immunotherapy and Biomarkers (18 papers), Heart Rate Variability and Autonomic Control (18 papers) and Gestational Trophoblastic Disease Studies (11 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (732 citations), Biological Psychiatry (107 citations), Complementary and alternative medicine (347 citations) and Immunology (619 citations). Peter Schmid has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andrew Conrad, Philip Savage, Dave S.�B. Hoon, Kurt Possinger, Javier Cortés, Tilman Steinert, D L Morton, Bernd Flath, K. Possinger and Serge P. von Duvillard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Medicine & Science in Sports & Exercise and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.